Device Trial Radar · NCT07696572
EUS Procedures Using RIVOS™ EUS Access Device
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Jul 13, 2026
Primary completion
Jul 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Orlando Health, Inc.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 10, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Conditions
- Pancreatic Fluid Collections
- Biliary Obstruction
- Pancreatic Duct Obstruction
- Chronic Pancreatitis
- Pancreatic Cancer Non-resectable
Interventions
EUS-guided intervention using the RIVOS™ EUS access deviceDevice
EUS-guided intervention using the RIVOS™ EUS access device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Technical successTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Orlando Health Digestive Health Institute
Orlando, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.